Trial Profile
Doxapram as an Additive to Propofol Sedation in Sedation for Endoscopic Retrograde Cholangiopancreatography
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2021
Price :
$35
*
At a glance
- Drugs Doxapram (Primary)
- Indications Hypoxia; Sedation
- Focus Therapeutic Use
- 02 Dec 2016 Status changed from not yet recruiting to completed.
- 18 Feb 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017, according to ClinicalTrials.gov record.
- 18 Feb 2016 Planned initiation date changed from 1 Oct 2015 to 1 Apr 2016, according to ClinicalTrials.gov record.